article · Journal of the Egyptian Ophthalmological Society
Purpose To compare the results of three-snip punctoplasty with the placement of three everting interrupted sutures versus three-snip punctoplasty with mini-Monoka stent in managing punctual stenosis. Patients and methods Fifty adult patients underwent three-snip punctoplasty with three everting interrupted sutures in one eye (right eye) (group A), and the other eye (left eye) (group B) underwent three-snip punctopasty with mini-Monoka stent. The sutures and stent were removed 6 weeks after the surgery. Epiphora, punctal opening, tear height meniscus, fluorescein and disappearance test results were analyzed and compared to preoperative information. Results Hundred eyes of 50 patients with a median age of 59 years, and females accounted for 56% of the sample. Anatomical and functional success in the right eye (group A) was 87.8 and 85.7%, respectively. On the other hand, the left eye (group B) anatomical and functional success were 89.7 and 87.7%, respectively. Regarding epiphora, there was a statistically significant difference between presurgical and postsurgical follow-up examinations in both right and left groups regarding Munk score. Tear Meniscus Height (TMH) decreased all through the follow-up visits between the two groups, almost to half, with no significant difference between both groups. Conclusion Both three-snip punctoplasty with everting sutures and three-snip punctoplasty with mini-Monoka stent are successful techniques in the management of punctal stenosis.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/ejos.ejos_75_23
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.